Skip to main content
BFRI logo
BFRI
(NASDAQ)
Biofrontera Inc.
$0.81-- (--)
Loading... - Market loading

Biofrontera (BFRI) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Biofrontera Inc.
BFRINasdaq Stock MarketHealthcareDrug Manufacturers - Specialty & Generic

About Biofrontera

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone781 245 1325
Address
660 Main Street, 1st Floor Woburn, Massachusetts 01801 United States

Corporate Identifiers

CIK0001858685
CUSIP09077D100
ISINUS09077D2099
EIN47-3765675
SIC2834

Leadership Team & Key Executives

Dr. Hermann Luebbert Ph.D.
Chief Executive Officer, President and Chairman
Eugene Frederick Leffler III
Chief Financial Officer
Erica F. Gates CPA, M.B.A.
Senior Director of Finance and Principal Accounting Officer
Jon Lyons M.B.A., Ph.D.
Vice President of Scientific and Medical Affairs
Daniel Hakansson J.D.
Senior Corporate Counsel
Samantha Widdicombe
Senior Vice President of Sales and Marketing
George P. Jones
Chief Commercial Officer